Oprah Winfrey steps down from Weight Watchers board to promote weight loss drugs
Oprah Winfrey has resigned from the board of directors of Weight Watchers, where she has served for nearly a decade, to avoid any appearance of a conflict of interest as she promotes weight loss drugs.
Winfrey, who has been open about her struggles with weight loss, recently revealed that she has been taking the weight loss drug Ozempic. The drug, which is injected once a week, helps regulate blood sugar levels and has been shown to be effective in helping people lose weight.
Winfrey’s decision to step down from the Weight Watchers board comes as the company is increasingly focused on providing weight loss medication to its customers. In 2023, Weight Watchers acquired Sequence, a telehealth company that provides access to doctors who can prescribe weight loss drugs.
In a statement, Winfrey said that she wanted to be able to “talk about whatever I want to talk about” when it comes to weight loss, and that she felt that her position on the Weight Watchers board could be seen as a conflict of interest.
“I decided to leave the Weight Watchers board because this special was really important to me and I wanted to be able to talk about whatever I want to talk about,” Winfrey said on “Jimmy Kimmel Live!” on Thursday. “Weight Watchers is now in the business of being a weight health company that also administers drug medications for weight. I did not want to have the appearance of any conflict of interest.”
Winfrey’s decision to step down from the Weight Watchers board has been met with mixed reactions. Some people have praised her for her transparency and honesty, while others have questioned her motives.
Some critics have also pointed to Winfrey’s past associations with figures like Dr. Phil and Dr. Oz, who have been criticized for promoting questionable health products.
Dr. Phil, for example, has been sued multiple times by former guests who allege that he exploited them for ratings. Dr. Oz has been criticized for promoting products that lack scientific backing.
Despite the criticism, Winfrey remains one of the most influential people in the world. Her endorsement of Ozempic could have a significant impact on the weight loss industry.
It remains to be seen whether Winfrey’s new weight loss special will be a success. However, there is no doubt that she is a powerful force in the world of health and wellness.
Only time will tell what the long-term impact of Winfrey’s decision to step down from the Weight Watchers board will be. However, one thing is for sure: she is not afraid to speak her mind, even if it means ruffling a few feathers.
News
Lady Gaga Says Britney Spears Has ‘Changed the Course for Women’ in the Music Industry ‘Forever’
“You stood up for yourself and were so brave,” Lady Gaga wrote to Britney Spears after the end of the “Lucky” singer’s 13-year conservatorship PHOTO: KARWAI TANG/WIREIMAGE;…
Lady Gaga set to return to Las Vegas this summer for eight shows on her Jazz & Piano residency at Park MGM
Lady Gaga is putting back on her Poker Face for another round in Las Vegas. The New York City native, 37, is reviving her Lady Gaga Jazz & Piano residency for eight shows…
Why Lady Gaga Skipped the 2024 Met Gala
It’s been five years since Lady Gaga walked the Met Gala carpet, and while Little Monsters were hoping that this would finally be the year of the pop superstar’s…
AFTER “SWEEPING” THE RED CARPET, LADY GAGA AGAIN DAZZLED WITH A “MOVING” DRESS
In recent days, not only music lovers but also the audience of the big screen can’t help but sob when looking at Lady Gaga. Appearing as a star…
Lady Gaga on Feud with Ex-Friend Perez Hilton: It’s All ‘Rooted in Madonna’
“He’s just mad that I don’t want to hang out anymore because I don’t want to be around fake people,” the “ARTPOP” singer said of dissolving her…
Lady Gaga is glamorous on the red carpet at the Grammy Awards
Singer Lady Gaga with high hair, light makeup, and seductive off-shoulder dress appeared on the red carpet at the Grammy Awards ceremony. Lady Gaga appeared on the…
End of content
No more pages to load